Irritable bowel syndrome in adults: diagnosis and management
NICE
Controls regular meals, fluid, activity, soluble versus insoluble fibre, dietitian-guided exclusion diets, and aloe-vera discouragement.
Reviewed guidance
Enteric-coated peppermint-oil capsules may modestly improve IBS symptoms such as abdominal pain, bloating, and gas over the short term. Evidence quality is low and individual trials are mixed; long-term benefit has not been established.
Short-term relief of global IBS symptoms in adults using an oral enteric-coated peppermint-oil capsule comparable to studied products; not a claim for peppermint tea, leaf, food, aromatherapy, topical oil, or undiluted essential oil.
How to use it: Use only a labeled oral enteric-coated capsule intended for IBS-type gastrointestinal use. Do not substitute peppermint tea, food, inhalation, topical preparations, or homemade essential-oil capsules. Reassess if symptoms persist and address IBS subtype, diet, fibre, and other established therapies.
Peppermint oil can cause reflux, heartburn, belching, nausea, abdominal discomfort, and perianal burning. It may be unsuitable for people with significant GERD or hiatal hernia. Do not swallow undiluted essential oil or improvise capsule doses.
Get medical care for symptoms that are severe, last longer than expected, get worse, or otherwise concern you.
Practical ways to use the ingredient may not provide the same form or amount discussed in the evidence.
Product-selection guidance for the oral enteric-coated peppermint-oil form studied for short-term IBS symptom relief.
How to choose and use a labeled diluted topical peppermint-oil preparation without improvising an essential-oil dilution.
Evidence transparency
NICE
Controls regular meals, fluid, activity, soluble versus insoluble fibre, dietitian-guided exclusion diets, and aloe-vera discouragement.
NCCIH
Supports modest short-term peppermint-oil benefit, mixed trial results, low evidence quality, and lack of established long-term efficacy.
NIDDK
Controls diagnostic boundaries including anemia, rectal bleeding, black/bloody stool, weight loss, and family-history concerns.
NCCIH
Controls enteric-coated capsule specificity and reflux/heartburn adverse-effect boundaries.